DEA Listening Sessions Highlight Stakeholder Push for Registry and Signal Additional Comment Period
As mentioned in CCHP’s In-Focus last week, the Drug Enforcement Administration (DEA) held listening sessions on September 12 and 13 to gather more information on the proposals the agency made earlier this year regarding the use of telehealth to prescribe a controlled substance post-pandemic. Earlier this month, CCHP also provided a recap of DEA telehealth policy in our September newsletter, including the waiver of existing in-person requirements through November 11, 2023. For those interested in providing comment during the DEA listening sessions, the DEA implemented a request and approval process prior to the sessions for all comments/questions as described in the DEA notice.